COI.
close Submit Innovation
close
Healthcare & Life Sciences verified Verified Outcome TRL 9

R&D Data Platform Governance (Onyx)

domain Client: A global science-led healthcare company handshake Provider: Microsoft Azure / Palantir schedule Deploy: Q1 2022 (Maturity)
91 Impact
Enterprise Ready
Evidence Score: 4/10
Strength: Medium

Executive Summary

ANALYST: COI RESEARCH

To accelerate drug discovery, the company overhauled its R&D data foundations. By implementing strict governance on clinical trial data (FAIR principles: Findable, Accessible, Interoperable, Reusable), they created a unified data fabric that allows scientists to combine genomic data with clinical outcomes without breaching compliance.

rate_review Analyst Verdict

"Data governance is a life-or-death capability in Pharma. The shift from siloed spreadsheets to a governed data fabric reduces the 'data wrangling' time for scientists, directly impacting the speed of bringing new medicines to market."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Genetic and clinical data were stored in disparate systems with inconsistent metadata. Scientists spent weeks verifying if they had the right consent usage to analyze specific patient samples, slowing down the identification of drug targets.

psychology The Solution

The company built a data platform (Onyx) ensuring all ingested data is tagged with metadata regarding consent, provenance, and usage rights. Governance policies are automated, preventing unauthorized access to sensitive patient data while enabling rapid search for authorized users.

settings_suggest Technical & Deployment Specs

Integrations
LIMS, Azure Data Lake
Deployment Model
Private/Public Hybrid
Data Classification
Genomic / Clinical
Estimated TCO / ROI
High
POC Summary (2019-01-01 to 2020-01-01)

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Patient Re-identification Critical Strict de-identification pipelines and access logging.
Data Quality High Automated QC pipelines for genomic sequencing data.

trending_up Impact Trajectory

Audited value realization curve

Integration of >10 petabytes of R&D data Verified Outcome
Primary KPIAdoption by >3,000 scientists
Audit CycleReduction in target identification cycle time

policy Compliance & Gov

  • Standards: GxP, HIPAA, GDPR
  • Maturity (TRL): 9
  • Evidence Score: 4/10
  • Data Class: Genomic / Clinical

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for A global science-led healthcare company without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-860
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-860

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.